DE1568807B2 - - Google Patents

Info

Publication number
DE1568807B2
DE1568807B2 DE1568807A DE1568807A DE1568807B2 DE 1568807 B2 DE1568807 B2 DE 1568807B2 DE 1568807 A DE1568807 A DE 1568807A DE 1568807 A DE1568807 A DE 1568807A DE 1568807 B2 DE1568807 B2 DE 1568807B2
Authority
DE
Germany
Prior art keywords
calcium
succinic acid
succinates
commercially available
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1568807A
Other languages
German (de)
English (en)
Other versions
DE1568807A1 (de
DE1568807C3 (de
Inventor
Tadataka Tokio Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE1568807A1 publication Critical patent/DE1568807A1/de
Publication of DE1568807B2 publication Critical patent/DE1568807B2/de
Application granted granted Critical
Publication of DE1568807C3 publication Critical patent/DE1568807C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
DE1568807A 1965-12-16 1966-12-14 Verfahren zur Herstellung von aktiven Calciumsuccinaten in eis-Form Expired DE1568807C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP40077042A JPS498849B1 (cg-RX-API-DMAC7.html) 1965-12-16 1965-12-16

Publications (3)

Publication Number Publication Date
DE1568807A1 DE1568807A1 (de) 1970-04-02
DE1568807B2 true DE1568807B2 (cg-RX-API-DMAC7.html) 1974-06-12
DE1568807C3 DE1568807C3 (de) 1975-02-20

Family

ID=13622700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1568807A Expired DE1568807C3 (de) 1965-12-16 1966-12-14 Verfahren zur Herstellung von aktiven Calciumsuccinaten in eis-Form

Country Status (6)

Country Link
US (1) US3527798A (cg-RX-API-DMAC7.html)
JP (1) JPS498849B1 (cg-RX-API-DMAC7.html)
CH (1) CH480284A (cg-RX-API-DMAC7.html)
DE (1) DE1568807C3 (cg-RX-API-DMAC7.html)
FR (1) FR1505788A (cg-RX-API-DMAC7.html)
GB (1) GB1173615A (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs
RU2174508C1 (ru) * 2000-02-29 2001-10-10 Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана Способ получения сукцинатов d-элементов
RU2228183C2 (ru) * 2002-07-18 2004-05-10 ЗАО "НПО ПЦ Биофизика" Средство для трансмембранной доставки катионов двухвалентных металлов, обеспечивающее их включение во внутриклеточный синтез
RU2290395C8 (ru) * 2005-06-01 2007-06-27 Пятигорская государственная фармацевтическая академия Способ получения сукцината кальция
RU2315032C1 (ru) * 2006-04-27 2008-01-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Московская государственная академия ветеринарной медицины и биотехнологии имени К.И. Скрябина Способ получения сукцината марганца (ii) тетрагидрата
RU2638157C1 (ru) * 2016-09-19 2017-12-12 Евгений Ильич Маевский Способ получения комплексных кислых солей двухвалентных металлов дикарбоновых кислот

Also Published As

Publication number Publication date
JPS498849B1 (cg-RX-API-DMAC7.html) 1974-02-28
GB1173615A (en) 1969-12-10
US3527798A (en) 1970-09-08
DE1568807A1 (de) 1970-04-02
CH480284A (fr) 1969-10-31
FR1505788A (fr) 1967-12-15
DE1568807C3 (de) 1975-02-20

Similar Documents

Publication Publication Date Title
DE2708192B2 (de) Kristalline a -Form von 2- [4-(2-Furoyl)-piperazin -1-yl] -4-amino-6,7 -dimethoxy-chinazolinhydrochlorid und Verfahren zur Herstellung dieser kristallinen Verbindung
DE3014045A1 (de) Fuer kosmetische zwecke verwendbare praeparate und verfahren zur herstellung der wirkstoffe dieser praeparate
DE1568807C3 (de) Verfahren zur Herstellung von aktiven Calciumsuccinaten in eis-Form
DE112009002089T5 (de) Verfahren zur Herstellung von Ammoniumsalzen der Fumar- oder Bernsteinsäure
DE2725246C2 (cg-RX-API-DMAC7.html)
DE3002304C2 (cg-RX-API-DMAC7.html)
DE3310584C2 (cg-RX-API-DMAC7.html)
DE3730277A1 (de) Salz einer organogermaniumverbindung und dieses enthaltende arznei
DD160270A5 (de) Zusammensetzung zur bekaempfung von warmbluetigem ungeziefer
DE1141051B (de) Desinfektionsmittelgemisch
DE1493618A1 (de) Cumarinderivate und ein Verfahren zu ihrer Herstellung
DE1670378A1 (de) Verfahren zur Herstellung einer Verbindung aus Phenylbutazon und ss-Diaethylaminoaethylamid der p-Chlorphenoxyessigsaeure
DE68916912T2 (de) Zinncysteat, dessen Herstellung und dessen pharmazeutische und kosmetische Verwendungen.
DE1695043C2 (de) Pharmazeutische Zusammensetzungen mit sedativen und tranquillisierenden Eigenschaften
DE1768846B2 (de) Quartaere ammoniumverbindungen und verfahren zu ihrer herstellung
DE752754C (de) Verfahren zur Herstellung von wirksamen, kristallisierten Glucosiden aus Sennesdrogen
DE167849C (cg-RX-API-DMAC7.html)
DE1768445C (de) N substituierte beta Oxybutyramid semisuccinate, deren Salze und ihre Her stellung
AT263801B (de) Verfahren zur Herstellung des neuen Lactons des 2-Allyl-2-(β-oxypropyl)-malonsäureureids
DE1809256C3 (de) 4- (p- Diphenylyl) -3-hydroxy butyrohydroxamsäure, Verfahren zu ihrer Herstellung und dieses enthaltende pharmazeutische Präparate
DE1292644B (de) Neue Modifikation der Bernsteinsaeure
DE1593933C3 (de) Quarternäre Stickstoffverbindungen und Verfahren zu ihrer Herstellung
DE1518411C3 (de) N-Disubstituierte Aminoamidsäuren, Verfahren zu deren Herstellung und Verwendung dieser Verbindungen
DE1468406C (de) Verfahren zur Herstellung von 2,6 Carbonsaurediestern der Ascorbinsäure bzw Isoascorbinsaure
CH616448A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977